Sekimizu K Editor-in-Chief

Drug Discov Ther. 2007; 1(1):1.

Summary Full Text (PDF)

China-Japan enhance joint research cooperation for drug discoveries and development: News from CJMWDDT 2007 in Jinan, China.

Liu XY, Qu XJ, Tang W

Drug Discov Ther. 2007; 1(1):2.

Summary Full Text (PDF)

China’s new drug R&D is steadily advancing.

Xu WF

Drug Discov Ther. 2007; 1(1):3.

Summary Full Text (PDF)

Analysis on productivity of clinical studies across -- Asian countries a case comparison.

Takahashi K, Sengoku S, Kimura H

Drug Discov Ther. 2007; 1(1):4-8.

Summary Full Text (PDF)

Lack of polymorphisms in the coding region of the highly conserved gene encoding transcription elongationfactor S-II (TCEA1).

Ito T, Doi K, Matsumoto N, Kakihara F, Noiri E, Hasegawa S, Tokunaga K, Sekimizu K

Drug Discov Ther. 2007; 1(1):9-11.

Summary Full Text (PDF)

GMP implementation in China: A double-edged sword for the pharmaceutical industry.

Gai RY, Qu XJ, Lou HX, Han JX, Cui SX, Nakata M, Kokudo N, Sugawara Y, Kuroiwa C, Tang W

Drug Discov Ther. 2007; 1(1):12-13.

Summary Full Text (PDF)

Viral infectious disease and natural products with antiviral activity.

Kitazato K, Wang Y, Kobayashi N

Drug Discov Ther. 2007; 1(1):14-22.

Summary Full Text (PDF)

Target validation: A door to drug discovery.

Chen XP, Du GH

Drug Discov Ther. 2007; 1(1):23-29.

Summary Full Text (PDF)

Therapeutic potential of heat-processed Panax ginseng with respect to oxidative tissue damage.

Yokozawa T, Kang KS, Yamabe N, Kim HY

Drug Discov Ther. 2007; 1(1):30-44.

Summary Full Text (PDF)

Anti-depressant and anti-nociceptive effects of 1,4-benzodiazepine-2-ones based cholecystokinin (CCK₂) antagonists.

Lattmann E, Sattayasai J, Lattmann P, Billington DC, Schwalbe CH, Boonprakob J, Airarat W, Singh H, Offel M, Staaf A

Drug Discov Ther. 2007; 1(1):45-56.

Summary Full Text (PDF)

ONIOM DFT/PM3 calculations on the interaction between dapivirine and HIV-1 reverse transcriptase, a theoretical study.

Liang YH, Chen FE

Drug Discov Ther. 2007; 1(1):57-60.

Summary Full Text (PDF)

Studies on the development of rapidly disintegrating hyoscine butylbromide tablets.

Khattab IS, Zaghloul1 AA, Afouna MI

Drug Discov Ther. 2007; 1(1):61-64.

Summary Full Text (PDF)

Investigation of the binding behaviors of isonucleoside-incorporated oligonucleotides with complementary sequences.

Guan Z, Jin HW, Yang ZJ, Zhang LR, Zhang LH

Drug Discov Ther. 2007; 1(1):65-72.

Summary Full Text (PDF)

Modification of 15-akylidene andrographolide derivatives as alpha-glucosidase inhibitor.

Xu HW, Liu GZ, Dai GF, Wu CL, Liu HM

Drug Discov Ther. 2007; 1(1):73-77.

Summary Full Text (PDF)

Evaluation of transdermal permeability of pentoxifylline gel: in vitro skin permeation and in vivo microdialysis using Wistar rats.

Yan KS, Yan TX, Guo H, Li JZ, Wei LL, Wang C, Nie SF, Pan WS

Drug Discov Ther. 2007; 1(1):78-83.

Summary Full Text (PDF)